Table III.

Group data and within-group comparisons

	Group	Before Mean (SD)	After Mean (SD)	Follow-up Mean (SD)	After before mean difference (SD) [95% CI]	Effect size (WG)	p-value; effect size (BG)	Follow- up before mean difference (SD) [95% CI]	Effect size effect size (WG)	p-value; (BG)
Mini BEST	E	20.91 (1.3)	24.36 (0.67)	23.73 (0.79)	-3.45 (1.13) [-4.21; -2.7]*	-0.637	0.031-0.46	-2.82 (1.08) [-3.54; -2.09]*	-0.632	0.003-0.635
	C	20.73 (1.01)	23.09 (0.83)	22 (2.59)	-2.36 (1.21) [-3.17; -1.55]*	-0.631		-1.27 (0.9) [-1.88; -0.67]	-0.581
BBS	E	49.45 (2.58)	54.91 (1.3)	53.36 (1.29)	-5.45 (1.97) [-6.78; -4.13]*	-0.629	0.009-0.56	-3.91 (2.07) [-5.3; -2.52]*	-0.633	0.035-0.45
	C	48.82 (4.02)	52.09 (2.79)	51.09 (3.53)	-3.27 (2.20) [-4.75; -1.8]*	-0.630		-2.27 (2.72) [-4.1; -0.44]	-0.541
10MWT, m/s	E	1.01 (0.09)	1.19 (0.09)	1.17 (0.08)	-0.19 (0.12) [-0.27; -0.1]*	-0.598	0.2-0.273	-0.16 (0.11) [-0.23; -0.08]*	-0.588	0.061-0.4
	C	0.99 (0.04)	1.11 (0.07)	1.07 (0.06)	-0.12 (0.06) [-0.16; -0.08]*	-0.626		-0.08 (0.07) [-0.13; -0.04]*	-0.551
PDQ-39	E	43.72 (23.52)	28.23 (21.72)	26.11 (22.65)	15.49 (11.97) [7.45; 23.53]*	-0.626	0.554-0.126	17.61 (14.26) [8.02; 27.19]*	-0.568	0.532-0.133
	C	45.09 (22.32)	32.87 (19.5)	31.64 (19.35)	12.22 (8.57) [6.46; 17.98]*	-0.626		13.45 (12.62) [4.97; 21.93]*	-0.550
5STS, s	E	16.14 (3.29)	13.2 (2.03)	13.23 (1.69)	2.94 (2.31) [1.39; 4.49]*	-0.607	0.576-0.119	2.90 (2.88) [0.96; 4.84]*	-0.568	0.718-0.077
	C	18.14 (2.37)	15.83 (2.24)	15.23 (2.55)	2.30 (1.19) [1.51; 3.1]*	-0.626		2.90 (2.12) [1.48; 4.33]*	-0.626

^*Statistically significant (p < 0.016).

E: experimental; C: control; BBS: Berg Balance Scale; TUG: Timed up and Go; 5STS: 5 Times Sit to Stand; 10MWT: 10-Metre Walk Test; PDQ-39: Parkinson’s Disease Questionnaire - 39; SD: standard deviation; 95% CI: 95% confidence interval; WG: within-groups; BG: between-groups.